Peptide and peptide-based inhibitors of SARS-CoV-2 entry

To date, no effective vaccines or therapies are available against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pandemic agent of the coronavirus disease 2019 (COVID-19). Due to their safety, efficacy and specificity, peptide inhibitors hold great promise for the tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Schütz, Desiree, Ruiz-Blanco, Yasser B., Münch, Jan, Kirchhoff, Frank, Sanchez-Garcia, Elsa, Müller, Janis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665879/
https://www.ncbi.nlm.nih.gov/pubmed/33189768
http://dx.doi.org/10.1016/j.addr.2020.11.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665879/
https://www.ncbi.nlm.nih.gov/pubmed/33189768
http://dx.doi.org/10.1016/j.addr.2020.11.007

Ejemplares similares